View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML

HHS/FDA RIN: 0910-AI80 Publication ID: Spring 2023 
Title: ●Front-of-Package Nutrition Labeling 
Abstract:

This proposed rule would require the front of food labels to display certain nutrition information to help consumers, especially those with lower nutrition knowledge, make more informed dietary choices.  Front-of-package (FOP) nutrition labeling is intended to complement the Nutrition Facts label on packaged foods by giving consumers additional context to help them quickly and easily identify foods that are part of a healthy eating pattern. A variety of FOP labeling systems have been adopted in countries world-wide and the experience in these countries suggests that FOP labeling may aid the ability to make healthier choices.  This proposed rule is part of FDA’s nutrition efforts to help address the epidemic of diet-related chronic disease by, among other things, empowering consumers with nutrition information to help them more easily identify healthier choices and encouraging industry innovation to produce healthier foods.

 
Agency: Department of Health and Human Services(HHS)  Priority: Economically Significant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: Undetermined  Unfunded Mandates: Undetermined 
CFR Citation: 21 CFR 101.6 (new)   
Legal Authority: Not Yet Determined   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  12/00/2023 
Regulatory Flexibility Analysis Required: Undetermined  Government Levels Affected: Undetermined 
Federalism: Undetermined 
Included in the Regulatory Plan: No 
International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest.
RIN Data Printed in the FR: No 
Agency Contact:
Mark Kantor
Nutritionist
Department of Health and Human Services
Food and Drug Administration
CPK1 RM 3D034, HFS-830, 5001 Campus Drive,
College Park, MD 20740
Phone:240 402-2082
Email: mark.kantor@fda.hhs.gov